These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21985310)

  • 41. New Peptide-Conjugated Chlorin-Type Photosensitizer Targeting Neuropilin-1 for Anti-Vascular Targeted Photodynamic Therapy.
    Kamarulzaman EE; Gazzali AM; Acherar S; Frochot C; Barberi-Heyob M; Boura C; Chaimbault P; Sibille E; Wahab HA; Vanderesse R
    Int J Mol Sci; 2015 Oct; 16(10):24059-80. PubMed ID: 26473840
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Compared to purpurinimides, the pyropheophorbide containing an iodobenzyl group showed enhanced PDT efficacy and tumor imaging (124I-PET) ability.
    Pandey SK; Sajjad M; Chen Y; Pandey A; Missert JR; Batt C; Yao R; Nabi HA; Oseroff AR; Pandey RK
    Bioconjug Chem; 2009 Feb; 20(2):274-82. PubMed ID: 19191565
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents.
    Mukai H; Wada Y; Watanabe Y
    Ann Nucl Med; 2013 Aug; 27(7):625-39. PubMed ID: 23605059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single wavelength light-mediated, synergistic bimodal cancer photoablation and amplified photothermal performance by graphene/gold nanostar/photosensitizer theranostics.
    Wu C; Li D; Wang L; Guan X; Tian Y; Yang H; Li S; Liu Y
    Acta Biomater; 2017 Apr; 53():631-642. PubMed ID: 28161572
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A dual activatable photosensitizer toward targeted photodynamic therapy.
    Lau JT; Lo PC; Jiang XJ; Wang Q; Ng DK
    J Med Chem; 2014 May; 57(10):4088-97. PubMed ID: 24793456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Photocytotoxicity of a cyanine dye with two chromophores toward melanoma and normal cells.
    Murakami LS; Ferreira LP; Santos JS; da Silva RS; Nomizo A; Kuz'min VA; Borissevitch IE
    Biochim Biophys Acta; 2015 Jun; 1850(6):1150-7. PubMed ID: 25512065
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multifunctional nanoplatforms for fluorescence imaging and photodynamic therapy developed by post-loading photosensitizer and fluorophore to polyacrylamide nanoparticles.
    Gupta A; Wang S; Pera P; Rao KV; Patel N; Ohulchanskyy TY; Missert J; Morgan J; Koo-Lee YE; Kopelman R; Pandey RK
    Nanomedicine; 2012 Aug; 8(6):941-50. PubMed ID: 22115602
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Purpurinimides as photosensitizers: effect of the presence and position of the substituents in the in vivo photodynamic efficacy.
    Rungta A; Zheng G; Missert JR; Potter WR; Dougherty TJ; Pandey RK
    Bioorg Med Chem Lett; 2000 Jul; 10(13):1463-6. PubMed ID: 10888333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structure.
    Safavy A; Georg GI; Vander Velde D; Raisch KP; Safavy K; Carpenter M; Wang W; Bonner JA; Khazaeli MB; Buchsbaum DJ
    Bioconjug Chem; 2004; 15(6):1264-74. PubMed ID: 15546192
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison between porphin, chlorin and bacteriochlorin derivatives for photodynamic therapy: Synthesis, photophysical properties, and biological activity.
    Zhu W; Gao YH; Liao PY; Chen DY; Sun NN; Nguyen Thi PA; Yan YJ; Wu XF; Chen ZL
    Eur J Med Chem; 2018 Dec; 160():146-156. PubMed ID: 30336449
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure-activity relationship among purpurinimides and bacteriopurpurinimides: trifluoromethyl substituent enhanced the photosensitizing efficacy.
    Gryshuk A; Chen Y; Goswami LN; Pandey S; Missert JR; Ohulchanskyy T; Potter W; Prasad PN; Oseroff A; Pandey RK
    J Med Chem; 2007 Apr; 50(8):1754-67. PubMed ID: 17371002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. P-glycoprotein targeted photodynamic therapy of chemoresistant tumors using recombinant Fab fragment conjugates.
    Mao C; Qu P; Miley MJ; Zhao Y; Li Z; Ming X
    Biomater Sci; 2018 Oct; 6(11):3063-3074. PubMed ID: 30298866
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative in vitro and in vivo studies on long-wavelength photosensitizers derived from bacteriopurpurinimide and Bacteriochlorin p6: fused imide ring enhances the in vivo PDT efficacy.
    Chen Y; Potter WR; Missert JR; Morgan J; Pandey RK
    Bioconjug Chem; 2007; 18(5):1460-73. PubMed ID: 17705415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BODIPY-doped silica nanoparticles with reduced dye leakage and enhanced singlet oxygen generation.
    Wang Z; Hong X; Zong S; Tang C; Cui Y; Zheng Q
    Sci Rep; 2015 Jul; 5():12602. PubMed ID: 26211417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long circulating half-life and high tumor selectivity of the photosensitizer meta-tetrahydroxyphenylchlorin conjugated to polyethylene glycol in nude mice grafted with a human colon carcinoma.
    Westerman P; Glanzmann T; Andrejevic S; Braichotte DR; Forrer M; Wagnieres GA; Monnier P; van den Bergh H; Mach JP; Folli S
    Int J Cancer; 1998 Jun; 76(6):842-50. PubMed ID: 9626351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polyacrylamide-based biocompatible Nanoplatform enhances the tumor uptake, PET/fluorescence imaging and anticancer activity of a chlorophyll analog.
    Gupta A; Wang S; Marko A; Joshi P; Ethirajan M; Chen Y; Yao R; Sajjad M; Kopelman R; Pandey RK
    Theranostics; 2014; 4(6):614-28. PubMed ID: 24723983
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Photosensitizer (PS)/polyhedral oligomeric silsesquioxane (POSS)-crosslinked nanohybrids for enhanced imaging-guided photodynamic cancer therapy.
    Zhu YX; Jia HR; Chen Z; Wu FG
    Nanoscale; 2017 Sep; 9(35):12874-12884. PubMed ID: 28686273
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Controlled modulation of serum protein binding and biodistribution of asymmetric cyanine dyes by variation of the number of sulfonate groups.
    Hamann FM; Brehm R; Pauli J; Grabolle M; Frank W; Kaiser WA; Fischer D; Resch-Genger U; Hilger I
    Mol Imaging; 2011 Aug; 10(4):258-69. PubMed ID: 21521558
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of chirality on cellular uptake, imaging and photodynamic therapy of photosensitizers derived from chlorophyll-a.
    Srivatsan A; Pera P; Joshi P; Wang Y; Missert JR; Tracy EC; Tabaczynski WA; Yao R; Sajjad M; Baumann H; Pandey RK
    Bioorg Med Chem; 2015 Jul; 23(13):3603-17. PubMed ID: 25936263
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy.
    Song C; Xu W; Wei Z; Ou C; Wu J; Tong J; Cai Y; Dong X; Han W
    J Mater Chem B; 2020 Jan; 8(4):648-654. PubMed ID: 31898718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.